Why the study?
Does diabetes worsen long-term outcomes in STEMI patients undergoing primary angioplasty with bare metal or drug-eluting stents?
Population
6,298 ST-segment elevation myocardial infarction patients undergoing primary angioplasty, pooled from 11…
Comparison
Presence of diabetes mellitus vs Absence of diabetes mellitus
Design
Meta-analysis
Follow-up
1,201 ± 441 days
Authors
Loading...
Diabetes heightens long-term mortality and ischemic risks after primary angioplasty in STEMI; confirms diabetes as an independent predictor despite contemporary stents.
Does diabetes worsen long-term outcomes in STEMI patients undergoing primary angioplasty with bare metal or drug-eluting stents?
Diabetes remains a strong independent predictor of long-term mortality, reinfarction, and stent thrombosis in STEMI patients undergoing primary angioplasty, though DES use mitigates the excess risk of target vessel revascularization.
Luca et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: